In the US, we are seeing some sharp rises in daily new cases in some places – sometimes the new case counts are the highest ever observed and with positivity rates well above 10%. News media selectively makes the attributions quickly or, on the other “side”, seemingly ignores it altogether.
(from
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html?action=click&module=Top%20Stories&pgtype=Homepage)
In the US, the perceived risk is clearly delineated by political party. Republicans are far more likely to downplay the risk and to desire a speedy and complete reopening. Democrats estimate the risk as being greater, and while wanting reopening also, they want it to be slower and to be more systematic/cautious. State and Local governments also vary widely on when they “closed” and when they “reopened” and by how much.
The case fatality rate, however, continues to decline. Around the time that the US hit 100K fatalities, a study reported that 40K deaths were related to nursing homes, long term care facilities and the like. That amazed me as I knew that the elderly are the most vulnerable population, but I had not realized that institutionally, it made up 40% of the fatalities (not all elderly people are in rest homes). I think that we finally have a handle on that situation - isolation, testing and tracing - and maybe combined with some better triage and treatment protocols.
It will be morbidly interesting to see if fatality rates rise along with new cases in those areas where we are seeing them. I don't think the increase will be as proportional as earlier.
As I stated earlier, I do think that we will have a monoclonal antibody treatment by the fall (by the end of the fall). It will be effective and it will be something of a game changer particularly with respect to school openings for the new year. Within a few months of the first, there will be several more, but with some big issues surrounding costs. This, I predict, will be a big election issue as part of healthcare that people can relate to easily. Who gets them and who pays and how much?
An effective vaccine is much further down the road in my view (I hope I am wrong).
It will also be morbidly interesting to see if we observe any rollbacks in opening up. I would think that this is going to, again, fall along political lines.
As long as we keep some integrity in the data collection, I think we will be able to refine how we re-open Even in my own behavior, I am adjusting my acceptable risk and I think everybody is to some extent. I mentioned getting a haircut earlier and yesterday I went to a hardware store to get parts to fix a dripping faucet (three hours of online research and then get in and get out), I didn’t want to wait a week or two for the wrong part to arrive.
There may be more home cooking and gardening in the US than ever.
I can’t even keep up with what is happening in places like Brazil and elsewhere. It is stressful and I cope by trying to restrict my interests to more local concerns and limit the number of study reports that I read.
I also think that high unemployment and the summer weather, combined with lower likelihood of hospitalization for young adults, does a lot toward reinforcing a lot of fears that I have.